All ICD10 Codes

DRG 436

Medical DRG

Malignancy of Hepatobiliary System or Pancreas with CC

TypeMedicalMDC07Dx Codes25

What is MS-DRG 436?

MS-DRG 436 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 07 (MDC 07) with a Complication or Comorbidity (CC). It maps to 25 ICD-10-CM diagnosis codes. For FY 2026 it carries a relative weight of 1.1311 with a geometric mean length of stay of 3.3 days and an arithmetic mean of 4.3 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.

Classification
Medical DRG
Diagnosis-driven grouping
MDC
Major Diagnostic Category 07
Linked Codes
25 diagnosis
Billable Dx
100%
25 of 25 shown

FY 2026 Payment Data

Official values from Table 5 of the FY 2026 IPPS Final Rule (CMS).

Relative Weight
1.1311
Payment multiplier vs. average case (1.0)
Geometric Mean LOS
3.3 days
Used for transfer payment calculations
Arithmetic Mean LOS
4.3 days
Average length of stay
Post-Acute Transfer
No
Not subject to the transfer policy

Related MS-DRGs in This Severity Group

The same clinical condition is split into separate DRGs by complication severity. MCC pays more than CC, which pays more than no CC/MCC.

DRGTitleRel. WeightGMLOS
435Malignancy of Hepatobiliary System or Pancreas with MCC1.83674.8 days
436Malignancy of Hepatobiliary System or Pancreas with CCThis page1.13113.3 days
437Malignancy of Hepatobiliary System or Pancreas without CC/MCC0.85332.4 days

Linked ICD-10-CM Diagnosis Mappings

  • C22.0

    Liver cell carcinoma

    BillableChapter 2
  • C22.1

    Intrahepatic bile duct carcinoma

    BillableChapter 2
  • C22.2

    Hepatoblastoma

    BillableChapter 2
  • C22.3

    Angiosarcoma of liver

    BillableChapter 2
  • C22.4

    Other sarcomas of liver

    BillableChapter 2
  • C22.7

    Other specified carcinomas of liver

    BillableChapter 2
  • C22.8

    Malignant neoplasm of liver, primary, unspecified as to type

    BillableChapter 2
  • C22.9

    Malignant neoplasm of liver, not specified as primary or secondary

    BillableChapter 2
  • C23

    Malignant neoplasm of gallbladder

    BillableChapter 2
  • C24.0

    Malignant neoplasm of extrahepatic bile duct

    BillableChapter 2
  • C24.1

    Malignant neoplasm of ampulla of Vater

    BillableChapter 2
  • C24.8

    Malignant neoplasm of overlapping sites of biliary tract

    BillableChapter 2
  • C24.9

    Malignant neoplasm of biliary tract, unspecified

    BillableChapter 2
  • C25.0

    Malignant neoplasm of head of pancreas

    BillableChapter 2
  • C25.1

    Malignant neoplasm of body of pancreas

    BillableChapter 2
  • C25.2

    Malignant neoplasm of tail of pancreas

    BillableChapter 2
  • C25.3

    Malignant neoplasm of pancreatic duct

    BillableChapter 2
  • C25.4

    Malignant neoplasm of endocrine pancreas

    BillableChapter 2
  • C25.7

    Malignant neoplasm of other parts of pancreas

    BillableChapter 2
  • C25.8

    Malignant neoplasm of overlapping sites of pancreas

    BillableChapter 2
  • C25.9

    Malignant neoplasm of pancreas, unspecified

    BillableChapter 2
  • C78.7

    Secondary malignant neoplasm of liver and intrahepatic bile duct

    BillableChapter 2
  • C7B.02

    Secondary carcinoid tumors of liver

    BillableChapter 2
  • D01.5

    Carcinoma in situ of liver, gallbladder and bile ducts

    BillableChapter 2
  • D37.6

    Neoplasm of uncertain behavior of liver, gallbladder and bile ducts

    BillableChapter 2